Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rola Gharib

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Cutis|September 15, 2015
Dry scaly rashKaitlin Vaughan Peters, Roxann L Powers, Rola Gharib
Journal of Drugs in Dermatology : JDD|August 2, 2024
Rapid Remission of Plaque Psoriasis With Bimekizumab TreatmentRama Abdin, Rola Gharib, Christopher G Bunick, et al.
Journal of Occupational and Environmental Medicine|May 21, 2016
Genetic Basis of Irritant Susceptibility in Health Care WorkersBerran Yucesoy, Yerkebulan Talzhanov, M Michael Barmada, et al.
Journal of Immunotoxicology|June 4, 2016
Association of MHC region SNPs with irritant susceptibility in healthcare workersBerran Yucesoy, Yerkebulan Talzhanov, M Michael Barmada, et al.
The New England Journal of Medicine|October 27, 2023
Phase 3 Trial of Nemolizumab in Patients with Prurigo NodularisShawn G Kwatra, Gil Yosipovitch, Franz J Legat, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Cutis|September 15, 2015
Dry scaly rashKaitlin Vaughan Peters, Roxann L Powers, Rola Gharib
Journal of Drugs in Dermatology : JDD|August 2, 2024
Rapid Remission of Plaque Psoriasis With Bimekizumab TreatmentRama Abdin, Rola Gharib, Christopher G Bunick, et al.
Journal of Occupational and Environmental Medicine|May 21, 2016
Genetic Basis of Irritant Susceptibility in Health Care WorkersBerran Yucesoy, Yerkebulan Talzhanov, M Michael Barmada, et al.
Journal of Immunotoxicology|June 4, 2016
Association of MHC region SNPs with irritant susceptibility in healthcare workersBerran Yucesoy, Yerkebulan Talzhanov, M Michael Barmada, et al.
The New England Journal of Medicine|October 27, 2023
Phase 3 Trial of Nemolizumab in Patients with Prurigo NodularisShawn G Kwatra, Gil Yosipovitch, Franz J Legat, et al.
Pageof 1